Adaptive Biotechnologies ADPT Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's operating margin?
- Adaptive Biotechnologies (ADPT) reported operating margin of -15.8% in Q1 2026.
- How has Adaptive Biotechnologies's operating margin changed year-over-year?
- Adaptive Biotechnologies's operating margin increased by 79.1% year-over-year, from -75.7% to -15.8%.
- What is the long-term trend for Adaptive Biotechnologies's operating margin?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating margin has grown at a -33.2% compound annual growth rate (CAGR), from -155.3% to -20.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.